MPMichel Perreault

Michel Perreault

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michel Perreault has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Évitement et exposition : perspective de personnes aux prises avec un trouble panique

    by Camille Blouin, Rebeka Lussier, Claude Bélanger, Michel Perreault

    Plusieurs personnes souffrant d’un trouble panique demeurent insatisfaites des améliorations perçues suite aux traitements reçus. L’objectif de cette étude est de documenter leur perspective quant à l’évitement et à l’exposition pour mieux comprendre comment cela influence leur rétablissement. Huit personnes ont participé à des entrevues semi-dirigées analysées selon la méthode de thématisation en continu de Paillé et Mucchielli (2016). Les résultats mettent en lumière 14 facteurs qui influenceraient leur propension à s’exposer ou non aux situations anxiogènes. Par cette analyse fine du vécu des personnes avec un trouble panique, cette étude confirme sur le terrain le modèle théorique du trouble panique tel que suggéré par la recherche empirique et quantitative. Elle contribue ainsi à une meilleure compréhension du trouble, permet d’orienter les interventions cliniques et offre des pistes pour la recherche future.

  • New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review

    by Niamh Power, Léonie Archambault, Michel Perreault

    Changes to the landscape of opioid use have occurred throughout the past two decades. Opioid agonist treatment (OAT) plays an important role in reducing opioid-related harms. Yet, people with opioid use disorder (PWOUD) face issues with access and retention. This scoping review sought to provide an up-to-date synthesis on barriers and facilitators to OAT. Ninety-three studies were included. Major barriers included cost, waiting lists, and negative public attitudes toward treatment. Prominent facilitators included OAT education and flexible treatment conditions such as telehealth-delivered OAT. In prison settings, limited support with treatment referral was a barrier. Fear of judgement was a challenge for pregnant people. There was a lack of information on barriers and facilitators specific to PWOUD dealing with chronic pain or mental health comorbidities. Results highlight new challenges in reaching an increasingly heterogeneous PWOUD population. Findings underline the potential for recent advancements in treatment modalities to promote access and retention.


  • Open Access

    The current state of knowledge on care for co‐occurring chronic pain and opioid use disorder: A scoping review

    by Léonie Archambault, Karine Bertrand, Marc O. Martel, Mélanie Bérubé, Salima Belhouari, Michel Perreault

    Background and Aims: Opioid use disorder often co‐occurs with chronic pain but assessment and treatment of these co‐occurring disorders is complex. This review aims to identify current treatments and delivery models for co‐occurring chronic pain and opioid use disorder (OUD) documented in the scientific literature. Design: Scoping review. Methods: The review was conducted in six databases in June 2022 (no time limit): CINAHL, PsycINFO, Web of Science, Cochrane, PubMed and Embase. The PRISMA‐ScR checklist was used to guide reporting. Results: Forty‐seven publications addressing the issue of co‐occurring chronic pain and OUD management were included. Randomized controlled trials provide evidence for the effectiveness of opioid agonist treatments (OAT) such as methadone or buprenorphine/naloxone, as well as for combining OAT with Mindfulness‐Oriented Recovery Enhancement or cognitive behavioural therapy. A number of other pharmacological treatments (opioid and nonopioid), nonpharmacological treatments (e.g. physiotherapy) and service delivery models (e.g. simultaneous treatment of comorbidities, interdisciplinary and interprofessional collaboration) are also underlined. In most cases, authors recommend a combination of strategies to meet patient needs. Conclusions: The scoping review reveals gaps in evidence‐based knowledge to effectively care for co‐occurring chronic pain and OUD, but several experts recommend the uptake of known ‘best’ practices such as integrated treatment of the multiple biopsychosocial dimensions of the co‐occurring disorders as well as collaborative interdisciplinary work. Clinical Relevance: Improving services is dependent on alleviating barriers such as working in silos, the costs associated with nonpharmacological treatments, and the double stigma associated with pain in people with a substance use disorder.


  • Open Access

    People with opioid use disorders: A taxonomy of treatment entrants to support the development of a profile‐based approach to care

    by Léonie Archambault, Karine Bertrand, Didier Jutras‐Aswad, Eva Monson, El Hadj Touré, Michel Perreault

    Introduction People with opioid use disorders (OUD) present with high levels of medical and psychosocial vulnerabilities. In recent years, studies have highlighted a shift in demographic and biopsychosocial profiles of people with OUD. In order to support the development of a profile-based approach to care, this study aims to identify different profiles of people with OUD in a sample of patients admitted to a specialised opioid agonist treatment (OAT) facility.Methods Twenty-three categorical variables (demographic, clinical, indicators of health and social precariousness) were retrieved from a sample of 296 patient charts in a large Montreal-based OAT facility (2017-2019). Descriptive analyses were followed by a three-step latent class analysis (LCA) to identify different socio-clinical profiles and examine their association with demographic variables.Results The LCA revealed three socio-clinical profiles: (i) "polysubstance use with psychiatric, physical and social vulnerabilities " (37% of the sample); (ii) "heroin use with vulnerabilities to anxiety and depression " (33%); (iii) "pharmaceutical-type opioid use with vulnerabilities to anxiety, depression and chronic pain " (30%). Class 3 individuals were more likely to be aged 45 years and older.Discussion and Conclusion While current approaches (such as low- and regular-threshold services) may be suited for many OUD treatment entrants, there may be a need to improve the continuum of care between mental health, chronic pain, and addiction services for those characterised by the use of pharmaceutical-type opioids, chronic pain and older age. Overall, the results support further exploring profile-based approaches to care, tailored to subgroups of patients with differing needs or abilities.


  • Implementation facilitators and barriers to the expansion of a peer-led overdose prevention program

    by Michel Perreault, Marie-Anne Ferlatte, Élise Lachapelle, Guillaume Tremblay, Diana Milton

    In Canada, there has been a substantial increase of opioid overdoses in recent years. PROFAN, a peer-led overdose prevention initiative, was successfully implemented in Montreal, Quebec, for people who use drugs (PWUD), or those likely to witness overdoses. The worsening of the situation during the COVID-19 pandemic sparked the need to expand the program across the province. Individual interviews were conducted with 17 key informants from 12 health regions to identify implementation facilitators and barriers. A thematic analysis was conducted based on emerging themes. Four main facilitators were reported: 1) presence of an active peer network involved with harm reduction in the region, 2) collaboration among community and public health sectors, 3) stakeholders’ awareness of opioid situation, and 4) perceived appropriateness of training. Six main barriers also emerged: 1) geographical isolation, 2) existing offer of similar services, 3) difficulty reaching isolated PWUD, 4) stigmatization of PWUD, 5) unwillingness of stakeholders to address situation, and 6) lack of funding stability. The expansion achieved by the PROFAN program highlights the ability of a peer-driven community organization to lead an overdose prevention program when provided with funding and support from government health agencies and partnerships with other organizations such as addiction worker associations.


  • Improving Harm Reduction Services: A Qualitative Study on the Perspectives of Highly Marginalized Persons Who Inject Drugs in Montreal

    by Hélène Poliquin, Michel Perreault, Ana C. Villela Guilhon, Karine Bertrand

    Harm reduction (HR) is an alternative to the moralization of drug use and a pragmatic public health approach aimed at minimizing harms associated with use. This study sought to gain the perspectives of persons who inject drugs (PWID) on the adequacy of services provided by HR organizations in Montreal. Twenty-two semi-structured interviews and two focus groups were conducted with 30 participants. Some of the key advantages of HR perceived by participants include access to injection equipment, psychosocial support, and reduced social isolation. However, many wanted more opportunities for social insertion and greater value to be placed on their knowledge and life experiences (e.g., experiential knowledge of the street scene, drug use, sex work, or homelessness). This study suggests that PWID who access HR services in Montreal are interested in paid work opportunities in environments that promote power sharing, and activities that are conducted and managed by and for them.


  • Open Access

    Identifying and Exploring Sustainability Determinants of Mental Health Recovery-Oriented Interventions: A Mixed Methods Study Protocol

    by Eleni Sofouli, Shannon Wiltsey-Stirman, Danielle Groleau, Michel Perreault, Myra Piat

    Mental health recovery is the new paradigm in the mental health service delivery system worldwide. Recovery-oriented services go beyond traditional clinical care that is centered on symptom remission, aiming to help people: restore social connections with other individuals and the community; develop hope and optimism for the future; reconstruct an identity beyond that of a “mental patient”; discover meaning in life; and feel empowered to gain control over treatment (CHIME framework). Over the last ten years, several efforts at implementation of recovery-oriented interventions have been documented in the scientific literature. However, little attention has been given to their sustainability, even though it is reported that not all health interventions can fully sustain their activities beyond the initial implementation phase. The aim of this mixed methods case study is to better understand the factors that determine the sustainability of two recovery-oriented interventions (peer support and recovery training) after their roll-out in four organizations in Canada that provide community housing for adults with mental health challenges. Qualitative and quantitative data will be collected from managers, service providers, and implementation team members that oversaw the implementation process along with organizational documents. Data collection and analysis will be guided by the Consolidated Framework for Sustainability Constructs in Healthcare, the Framework for Reporting Adaptations and Modifications, and the Program Sustainability Assessment Tool. Findings will expand our current evidence base on the intersection of sustainability and mental health recovery interventions that remains under-explored.


  • Open Access

    Problematic Opioid Use: A Scoping Literature Review of Profiles

    by Léonie Archambault, Karine Bertrand, Michel Perreault

    Background and Objectives: Problematic opioid use can be defined as opioid use behaviors leading to social, medical, or psychological consequences. In some instances, people presenting problematic opioid use can also meet criteria for an opioid use disorder. A growing body of literature highlights different types of people who use opioids, with contrasting characteristics and initiation patterns. In recent years, dynamic trends in opioid use have been documented and studies have demonstrated a shift in profiles. Methods: A scoping literature review was conducted to identify profiles of people presenting problematic opioid use, in order to support the development of tailored interventions and services. Results: Nine articles met the inclusion criteria. Five classifications emerge from the literature reviewed to distinguish types of people presenting problematic opioid use, according to: (1) the type of opioids used, (2) the route of opioid administration, (3) the level of quality of life, (4) patterns of other drugs used, and (5) dependence severity. While samples, concepts, and measurement tools vary between studies, the most salient finding might be the distinct profile of people presenting problematic use of pharmaceutical-type opioids. Discussion and Conclusions: This scoping review highlights that few studies address distinctive profiles of people presenting problematic opioid use. Geographical and chronological differences suggest that local timely assessments may be needed to tailor the service offer to specific needs. Scientific Significance: Future studies should focus on providing a deep understanding of distinct experiential perspectives and service needs, through exploratory quantitative and qualitative designs.


  • Profiles of Patients with Opioid Use Disorders Presenting a History of Suicidal Ideations and Attempts

    by Léonie Archambault, Didier Jutras-Aswad, El Hadj Touré, Ana Carolina Artunduaga, Stéphane Roy, David Barbeau, Michel Perreault

    Suicide rates are higher for people with an opioid use disorder, compared to the general population. This study aims to characterize opioid agonist treatment entrants who present a history of suicidal ideations or suicide attempts, according to concurrent comorbidity profiles, in an opioid use disorder treatment facility. A chart review design was used. Data was collected from 202 patient files. Bivariate and multivariate analyses were conducted. In multivariate analysis, patients with a diagnosis or symptoms of a mood disorder were 2.48 [1.01 – 6.11] times more likely to report suicidal ideations and 2.64 [1.05 – 6.62] times more likely to report suicide attempts. Those with a diagnosis or symptoms of an anxiety disorder were 2.41 [1.01 – 5.81] times more likely to report suicidal ideations. Patients who report chronic pain were 2.59 [1.06 – 6.35] times more likely to report suicidal ideations as well. The probability to report suicide attempts was 5.09 [1.16 – 22.4] times higher for those with a confirmed or suspected personality disorder. Clinicians should bear in mind the high suicide rates in people with opioid use disorder, as well as the importance of addressing suicidal risk and providing easy access to mental health and chronic pain treatment as part of the service offer in opioid agonist treatment. Future research should focus on evaluating the effectiveness of treatments aimed at addressing the needs of opioid agonist treatment patients with interrelated mental health and pain comorbidity profiles to reduce risks associated with suicide.


  • Open Access

    Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders

    by Léonie Archambault, Marie-Ève Goyer, Judith Sabetti, Michel Perreault

    Engagement of health care professionals represents an important factor for successful implementation of new practices. To support these professionals’ involvement, it is essential to understand the...